Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Return on Invested Capital (2024)

Historic Return on Invested Capital for CorMedix (CRMD) over the last 7 years, with Q3 2025 value amounting to 0.53%.

  • CorMedix's Return on Invested Capital rose 13700.0% to 0.53% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.53%, marking a year-over-year increase of 13700.0%. This contributed to the annual value of 0.51% for FY2022, which is 200.0% up from last year.
  • Per CorMedix's latest filing, its Return on Invested Capital stood at 0.53% for Q3 2025, which was up 13700.0% from 0.29% recorded in Q2 2025.
  • CorMedix's 5-year Return on Invested Capital high stood at 0.53% for Q3 2025, and its period low was 1.01% during Q2 2024.
  • In the last 4 years, CorMedix's Return on Invested Capital had a median value of 0.46% in 2021 and averaged 0.38%.
  • As far as peak fluctuations go, CorMedix's Return on Invested Capital tumbled by -2400bps in 2022, and later surged by 13700bps in 2025.
  • Over the past 4 years, CorMedix's Return on Invested Capital (Quarter) stood at 0.43% in 2021, then fell by -26bps to 0.54% in 2022, then soared by 46bps to 0.29% in 2024, then soared by 283bps to 0.53% in 2025.
  • Its Return on Invested Capital stands at 0.53% for Q3 2025, versus 0.29% for Q2 2025 and 0.29% for Q4 2024.